Table 1.
Baseline characteristics of two groups of SLE patients with high score and low score
| Variable | High score group (n = 54) |
Low score group (n = 50) |
|---|---|---|
| Age (years) | 33.88 ± 11.34 | 35.32 ± 10.8 |
| Sex (Male:Female) | 3: 51 | 6: 44 |
| BMI(kg/m2) | 23.36 ± 4.69 | 24 ± 4.34 |
| Systolic blood pressure(mmhg) | 116.48 ± 12.76 | 117.60 ± 9.38 |
| Diastolic blood pressure(mmhg) | 77.87 ± 8.4 | 79.20 ± 5.2 |
| Duration of disease(year) | 6.64 ± 3.96 | 5.2 ± 3.87 |
| Left ventricular ejection fraction | 64.32 ± 11.15 | 65.83 ± 9.75 |
| Hydroxychloroquine | 44(42%) | 37(34%) |
| Prednisolone | 52(50%) | 43(41%) |
| Cytotoxic drugs | 18(17.3%) | 14(13.5%) |
| Systemic Lupus Erythematous Disease Activity Index (SLEDAI) | 54(51.92%) | 50(48.07) |
*Values are means (standard deviation) or absolute numbers (proportions)
*All have no significant differences with non significant P value except SLEDAI which is significantly different in two groups (P value < 0.004)